Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023
Mon, December 18, 2023
Fri, December 15, 2023
Thu, December 14, 2023

Derek Archila Maintained (BPMC) at Buy with Increased Target to $115 on, Dec 19th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-115-on-dec-19th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $86 to $115 on, Dec 19th, 2023.

Derek has made no other calls on BPMC in the last 4 months.



There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 2 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $63 on, Friday, October 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $58 on, Friday, October 27th, 2023


These are the ratings of the 3 analyists that currently disagree with Derek


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023
  • Matthew Biegler of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $85 on, Friday, October 27th, 2023
  • Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $74 on, Friday, October 27th, 2023

Publication Contributing Sources